Effects of weight loss on the hormonal profile in obese, infertile women

Human Reproduction

Volumn 11, Issue 9, 1996, Pages 1884-1891

  Hollmann, Michaela ^a   Runnebaum, Benno ^a   Gerhard, Ingrid ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Infertility; Insulin resistance; Obesity; Weight reduction

Indexed keywords

ANDROSTANOLONE; ANDROSTENEDIONE; C PEPTIDE; CORTICOTROPIN; ESTRADIOL; FOLLITROPIN; GLUCOSE; GROWTH HORMONE; HYDROCORTISONE; INSULIN; LUTEINIZING HORMONE; PRASTERONE; PRASTERONE SULFATE; PROLACTIN;

ADULT; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOCRINE FUNCTION; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FOLLITROPIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; GROWTH HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERANDROGENISM; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MENSTRUAL IRREGULARITY; MENSTRUATION; OBESITY; PREGNANCY RATE; PROLACTIN BLOOD LEVEL; PSYCHOLOGICAL ASPECT; TREATMENT OUTCOME; WEIGHT REDUCTION;

EID: 0029821801     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.humrep.a019512     Document Type: Article

References (43)

1. Adashi, E.Y., Hsueh, A.J.W. and Yen, S.S.C. (1981) Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells. Endocrinology, 116, 1441-1449.
2. Adashi, E.Y., Resnick, C.E., D'Ercole, A.J. et al. (1985) Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function. Endocr. Rev., 6, 400-429.
3. Barbieri, R.L., Smith, S. and Ryan, K.J. (1988) The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism. Fertil. Steril., 50, 197-212.
4. Balen, A.H., Conway, G.S., Kaltsas, G. et al. (1995) Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum. Reprod., 10, 2107-2111.
5. Caro, J.F. (1991) Insulin resistance in obese and nonobese man. J. Clin. Endocrinol. Metab., 73, 691-696.
6. Ciucci, E., Giovannini, C., Bartoli, A. et al. (1988) Relationship Between Beta-Endorphin, ACTH, Insulin And Cortisol During Oral Glucose Tolerance Test In Treated Obesity. 12. Akt Ernährungsmed, Sonderdruck, 4. Jahrestagung Deutsche Gesellschaft für Adipositasforschung, Wien.
7. Clark, A.M., Ledger, W., Galletly, C. et al. (1995) Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum. Reprod., 10, 2705-2712.
8. Cordido, F., Casanueva, F.F. and Dieguez, C. (1989) Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity. J. Clin. Endocrinol. Metab., 68, 290-293.
9. Dunaif, A. (1986) Do androgens directly regulate gonadotrophin secretion in the polycystic ovary syndrome? J. Clin. Endocrinol. Metab., 63, 215-221.
10. Dunaif, A., Mandeli, J., Fluhr, H. and Dobrjansky, A. (1988) The impact of obesity and chronic hyperinsulinemia on gonadotrophin release and gonadal steroid secretion in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 66, 131-139.
11. Evans, D.J., Hoffmann, R.G., Kalkhoff, R.K. and Kissebah, A.H. (1983) Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolic aberrations in premenopausal women. J. Clin. Endocrinol. Metab., 57, 304-310.
12. Every, N.R., Boyko, E.J., Keane, E.M. et al. (1993) Blood pressure, insulin, and C-peptide levels in San Luis Valley, Colorado. Diabetes Care, 16, 1543-1550.
13. Gerhard, I. and Postneek, F. (1988) Möglichkeiten der Therapie durch Ohrakupunktur bei weiblicher Sterilität. Geburtsh. u. Frauenheilk., 48, 165-171.
14. Gerhard, I., Schlereth, I., Eggert-Kruse, W. et al. (1990) Bedeutung der Testosterone-, DHEAS- und Androstendionbestimmung im Rahmen der weiblichen Fertilitätsdiagnostik und -therapie. Fertilität, 6, 1-9.
15. Gerhard, I., Matthes, J. and Runnebaum, B. (1993) The induction of ovulation with pulsatile gonadotrophin-releasing hormone (GnRH) administration in hyperandrogenic women after down-regulation with buserelin or suppression with an oral contraceptive. Hum. Reprod., 8, 2033-2038.
16. Glass, A.R. (1989) Endocrine aspects of obesity. Med. Clin. N. Am., 73, 139-160.
17. Grenman, S., Rönnemaa, T., Irjala, K. et al. (1986) Sex steroid, gonadotrophin, cortisol, and prolactin levels in healthy, massively obese women: correlation with abdominal fat cell size and effect of weight reduction. J. Clin. Endocrinol. Metab., 63, 1257-1261.
18. Hamilton-Fairley, D., Kiddy, D., Anyaoku, V. et al. (1993) Response of sex hormone binding globulin and insulin-like growth factor binding protein-1 to an oral glucose tolerance test in obese women with polycystic ovary syndrome before and after caloric restriction. Clin. Endocrinol. (Oxf.), 39, 363-367.
19. Harlass, F.E., Plymate, S.R., Fariss, B.L. and Belts, R.P. (1984) Weight loss is associated with correction of gonadotrophin and sex steroid abnormalities in the obese anovulatory female. Fertil. Steril., 42, 649-652.
20. Hauner, H., Ditschuneit, H.H., Pal, S.B. and Pfeiffer, E.F. (1987) Fettgewebsverteilung und Adipositaskomplikationen bei ubergewichtigen Frauen mit und ohne Hirsutismus. Dtsch Med Wochenschr., 112, 709-713.
21. Herold, G. (1991) Arterielle Hypertonie. Blutdruckmessung. In Herold, G. (ed.), Innere Medizine. Köln, p. 215.
22. Hershcopf, R.J. and Bradlow, H.L. (1987) Obesity, diet, endogenous oestrogens, and the risk of hormone-sensitive cancer. Am. J. Clin. Nutr., 45, 283-289.
23. Immich, H. (1974) Medizinische Statistik. Schattauer, Stuttgart, New York.
24. Insler, V., Shoham, Z., Barash, A. et al. (1993) Polycystic ovaries in non-obese and obese patients: possible pathophysiological mechanism based on new interpretation of facts and findings. Hum. Reprod., 8, 379-384.
25. Kopelman, P.G., Pilkington, T.R.E., White, N. and Jeffcoate, S.L. (1980) Abnormal sex steroid secretion and binding in massively obese women. Clin. Endocrinol. (Oxf.), 12, 363-369.
26. Lanzone, A., Villa, P., Fulghesu, A.M. et al. (1995) The growth hormone response to growth hormone-releasing hormone is blunted in polycystic ovary syndrome: relationship with obesity and hyperinsulinaemia. Hum. Reprod., 10, 1653-1657.
27. Müller, M.J., Lautz, H.U., von zur Mühlen, A. et al. (1990) Pathogenese und Therapie der Adipositas. Dtsch. Med. Wochenschr., 115, 789-794.
28. Nestler, J.E., Clore, J.N. and Blackard, W.G. (1989): The central role of obesity (hyperinsulinemia) in the pathogenesis of the polycystic ovary syndrome. Am. J. Obstet. Gynecol., 161, 1095-1097.
29. Pasquali, R. and Casimirri, F. (1993) The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women. Clin. Endocrinol. (Oxf.), 39, 1-16.
30. Pasquali, R., Antenucci, D., Casimirri, F. et al. (1989) Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. J. Clin. Endocrinol. Metab., 68, 173-179.
31. Plymate, S.R., Matej, L.A., Jones, R.E. and Friedl, K.E. (1988) Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J. Clin. Endocrinol. Metab., 67, 460-474.
32. Poretsky, L. and Kalin, M.F. (1987) The gonadotropic function of insulin. Endocr. Rev., 8, 132-141.
33. Richelsen, B., Pedersen, S.B., Borglum, J.D. et al. (1994) Growth hormone treatment of obese women for 5 weeks: effect on body composition and adipose tissue LPL activity. Am. J. Physiol., 266, 197-216.
34. Rittmaster, R.S., Deshwal, N. and Lehman, L. (1993) The role of adrenal hyperandrogenism, insulin resistance, and obesity in the pathogenesis of polycystic ovarian disease. J. Clin. Endocrinol. Metab., 76, 1295-1300.
35. SAS Institute (1985) SAS® User's Guide: Basics, Version 5 Edition. SAS Institute, Cary, NC, 1290 pp.
36. Scavo, D., Barletta, C., Buzzetti, R. and Vagiri, D. (1988) Effects of caloric restriction and exercise on beta-endorphin, ACTH and cortisol circulating levels in obesity. Physiol. Behav., 42, 65-68.
37. Simonson, D.C. (1990) Hyperinsulinemia and its sequelae. Horm. Metab. Res. Suppl., 22, 17-25.
38. Stunkhard, A.J. (1986) Adipositas. In Uexhüll, Th.v. (ed.), Psychosomatische Medizin. Urban und Schwarzenberg, München, Wien, Baltimore, pp. 583-598.
39. Tabibzadeh, S., Kong, Q.F., Satyaswaroop, P.G. and Babaknia, A. (1996) Heat shock proteins in human endometrium throughout the menstrual cycle. Hum. Reprod., 3, 633-640.
40. Tiitinen, A., Pekonen, F., Stenman, U.H. and Laatikainen, T. (1990) Plasma androgens and oestradiol during oral glucose tolerance test in patients with polycystic ovaries. Hum. Reprod., 5, 242-245.
41. Wajchenberg, B.L., Marcondes, J.A.M., Mathor, M.B. et al. (1989) Free testosterone levels during the menstrual cycle in obese versus normal women. Fertil. Steril., 51, 535-537.
42. Yen, S.S.C. (1980) The polycystic ovary syndrome. Clin. Endocrinol., 12, 177-208.
43. Zumoff, B. (1988) Hormonal abnormalities in obesity. Acta Med. Scand. Suppl., 723, 153-160.